Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

129 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The natural history of COVID-19 in patients with inflammatory bowel disease: a nationwide study by the Hellenic Society for the study of IBD.
Bamias G, Kokkotis G, Christidou A, Christodoulou DK, Delis V, Diamantopoulou G, Fessatou S, Gatopoulou A, Giouleme O, Kafritsa P, Kalantzis C, Kapsoritakis A, Karatzas P, Karmiris K, Katsanos K, Kevrekidou P, Kosmidis C, Mantaka A, Mathou N, Michalopoulos G, Michopoulos S, Papaconstantinou I, Papatheodoridis G, Polymeros D, Potamianos S, Poulopoulos G, Protopapas A, Sklavaina M, Soufleris K, Theocharis G, Theodoropoulou A, Triantafillidis JK, Triantafyllou K, Tsiolakidou G, Tsironi E, Tzouvala M, Viazis N, Xourgias V, Zacharopoulou E, Zampeli E, Mantzaris GJ. Bamias G, et al. Among authors: papaconstantinou i. Eur J Gastroenterol Hepatol. 2021 Dec 1;33(1S Suppl 1):e810-e817. doi: 10.1097/MEG.0000000000002267. Eur J Gastroenterol Hepatol. 2021. PMID: 34402469 Free PMC article.
The role of variations within microRNA in inflammatory bowel disease.
Papaconstantinou I, Stamatis K, Tzathas C, Vassiliou I, Giokas G, Gazouli M. Papaconstantinou I, et al. Eur J Gastroenterol Hepatol. 2013 Apr;25(4):399-403. doi: 10.1097/MEG.0b013e32835c34ea. Eur J Gastroenterol Hepatol. 2013. PMID: 23466513 Review.
Fecal calprotectin measurement is a marker of short-term clinical outcome and presence of mucosal healing in patients with inflammatory bowel disease.
Kostas A, Siakavellas SI, Kosmidis C, Takou A, Nikou J, Maropoulos G, Vlachogiannakos J, Papatheodoridis GV, Papaconstantinou I, Bamias G. Kostas A, et al. Among authors: papaconstantinou i. World J Gastroenterol. 2017 Nov 7;23(41):7387-7396. doi: 10.3748/wjg.v23.i41.7387. World J Gastroenterol. 2017. PMID: 29151692 Free PMC article.
129 results